Analyses of visceral and subcutaneous white adipose tissue from mice and humans showed that MMP12 was upregulated in obesity at the mRNA and protein levels, which resulted in increased activity; this indicated that MMP12 may be a target for treatment and prevention of cardiometabolic diseases [54]. This evidence concerns the gene MMP12 and obesity disorder.